ACE and COVID-19: On the other hand, the second theory states that SARS-CoV interaction with ACE2 receptors will lead to exhaustion, leaving the ACE and angiotensin levels high enough to result in multi-system inflammation, and therefore, ACEI or ARB use is associated with less inflammation and thus less severe disease from COVID-19 [21].